Loo uus konto

Registreeru ning avasta:
  • Personaalsed erihinnad
  • Tellimuse staatuse info
  • Eeltäidetud ja kiire tellimuse vormistamine
  • Tellimuste ajalugu ning mugav kordustellimine
  • Nähtav toodete laoseis
Cart

Sinu ostukorv on tühi, lisa mõni toode

Kui e-poes sobivat toodet ei leidu, siis meie tootejuhid on hea meelega valmis aitama, küsi julgelt!

Tarne

0,00 €

Kokku: 0,00 €

image/svg+xml Sisene / Registreeru
Sisene või registreeru
Logi sisse Loo konto
Registreeru ning avasta:
  • Personaalsed erihinnad
  • Tellimuse staatuse info
  • Eeltäidetud ja kiire tellimuse vormistamine
  • Tellimuste ajalugu ning mugav kordustellimine
  • Nähtav toodete laoseis
1-placeholder

Tootekood 09COV33D

Contents (Cat No. 09COV33D):
Test device (individually in a foil pouch with desiccant) x25
Extraction buffer tube x25
Nozzle cap x25
Sterile swab x25
Buffer tube rack x2
STANDARD COVID-19 Ag Positive Control swab x1
STANDARD Respiratory Negative Control swab x1
Instructions for use x1

General description:
STANDARD Q COVID-19 Ag Test is a rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in human nasopharynx. This test is for administration by healthcare workers and labs only, as an aid to early diagnosis of SARS-CoV-2 infection in patient with clinical symptoms with SARS-CoV-2 infection. It provides only an initial screening test result. This product is strictly for medical professional use only and not intended for personal use. The administration of the test and the interpretation of the results should be done by a trained health professional. The result of this test should not be the sole basis for the diagnosis; confirmatory testing is required.

Kit storage and stability:

Store the kit at 2-30°C / 36-86°F out of direct sunlight. Kit materials are stable until the expiration date printed on the outer box. Do not freeze the kit.

Clinical evaluation
Clinical performance of STANDARD Q COVID-19 Ag Test was evaluated using 503 nasal samples at Central Research Lab in Bangalore, India. FDA EUAauthorized RT-PCR test (EURO Real Time SARS-CoV-2) was used as the comparator method in the study.
The positive percent agreement of STANDARD Q COVID-19 Ag Test using nasal swab as specimen and RT-PCR Test as reference assay is 97.12% (95% CI, 91.86 – 99.01%) and the negative percent agreement is 100% (95% CI, 99.05 – 100%).

Sensitivity: 97.12% (95% CI, 91.86% – 99.01%)
Specificity: 100% (95% CI, 99.05% – 100%)

Spetsifikatsioonid

Spetsifikatsioonid

Dokumendid

Hiljuti vaadatud

Ettevõttest

Nova Natura UAB

Kaštonų g. 56, Giraitės k, LT-54310,
Kaunas, Lithuania

nova@novabio.lt
Phone: +370 (620) 70159

Reg No 305063819

Nova Natura OÜ

Valukoja 8, 11415,
Tallinn, Estonia

nova@novabio.ee
Phone: +37251939223

Reg No 14758203

NOVA uudiskiri

Liituge meie uudiskirjaga!
ISO9001 1 e1593687280362